Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, Beijing, China.
Int J Gynaecol Obstet. 2023 May;161(2):536-543. doi: 10.1002/ijgo.14563. Epub 2022 Nov 26.
To compare maternal and neonatal outcomes between oxytocin and vaginal misoprostol induction in women with term prelabor rupture of membranes (PROM) and unfavorable cervixes.
In this retrospective study, 589 pregnant women with term singleton fetuses in cephalic presentation, reactive nonstress tests, PROM of 2-24 h duration, Bishop score <6, and no previous uterine surgery were reviewed and divided into oxytocin (n = 301) and misoprostol (n = 288) groups. The primary outcomes were the rate of vaginal delivery and delivery within 24 h.
After 24 h of induction, the misoprostol group showed a significantly higher proportion of vaginal delivery (64.6% vs. 49.5%, P < 0.001) and a lower cesarean section delivery rate (11.5% vs. 25.2%, P < 0.001) than the oxytocin group. More primiparas in the misoprostol group achieved vaginal delivery within 24 h than in the oxytocin group (60.5% vs. 45.4%, P = 0.001). Among primiparas, the misoprostol group had a significantly lower cesarean delivery rate (12.6% vs. 27.5%, P < 0.001).
Vaginal misoprostol induction in term PROM gravidas with unfavorable cervixes was associated with lower cesarean section and higher vaginal delivery rates within 24 h than oxytocin infusion. Vaginal misoprostol and oxytocin infusion had similar maternal and neonatal outcomes.
比较缩宫素与米索前列醇用于足月胎膜早破(PROM)且宫颈条件不佳产妇引产的母婴结局。
本回顾性研究纳入了 589 例足月、单胎头位、有反应性无应激试验、胎膜早破持续时间 2-24 小时、Bishop 评分<6 分且无既往子宫手术史的孕妇,将其分为缩宫素组(n=301)和米索前列醇组(n=288)。主要结局为阴道分娩率和 24 小时内分娩率。
诱导 24 小时后,米索前列醇组的阴道分娩率(64.6% vs. 49.5%,P<0.001)明显更高,剖宫产率(11.5% vs. 25.2%,P<0.001)更低。米索前列醇组中初产妇在 24 小时内阴道分娩的比例高于缩宫素组(60.5% vs. 45.4%,P=0.001)。在初产妇中,米索前列醇组的剖宫产率明显更低(12.6% vs. 27.5%,P<0.001)。
与缩宫素静脉滴注相比,米索前列醇阴道给药用于宫颈条件不佳的足月胎膜早破产妇,可降低剖宫产率,增加 24 小时内阴道分娩率。米索前列醇和缩宫素静脉滴注对母婴结局无显著影响。